Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV

COVID-19 - IVI

Frontiers Viral vector and nucleic acid vaccines against COVID-19: A narrative review

DNA vaccines against COVID-19: Perspectives and challenges - ScienceDirect

Inovio Pharmaceuticals, Inc. - INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine

Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination

SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines

Race for a Coronavirus Vaccine

Frontiers The Current Status of COVID-19 Vaccines

Vaccines, Free Full-Text

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine

Current clinical status of new COVID-19 vaccines and immunotherapy

SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies - ScienceDirect

Immunogenicity of a DNA vaccine candidate for COVID-19